Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹1000 |
Expense Ratio | 0.61 | 2.19 |
NAV | ₹24.08 | ₹79.46 |
Fund Started | 11 Feb 2019 | 03 Jul 2008 |
Fund Size | ₹899.17 Cr | ₹1021.24 Cr |
Exit Load | - | Exit load of 1%, if redeemed within 15 days. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -1.49% | -4.74% |
3 Year | 16.47% | 14.65% |
5 Year | 22.18% | 23.76% |
1 Year
3 Year
5 Year
Equity | 99.69% | 99.32% |
Cash | 0.31% | -4.20% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Interglobe Aviation Ltd. | 4.54% |
Hindustan Aeronautics Ltd. | 3.59% |
Vedanta Ltd. | 3.55% |
Divi's Laboratories Ltd. | 3.31% |
Varun Beverages Ltd. | 3.27% |
The Indian Hotels Company Ltd. | 3.13% |
Cholamandalam Investment and Finance Company Ltd. | 2.89% |
Tata Power Company Ltd. | 2.85% |
Power Finance Corporation Ltd. | 2.73% |
Avenue Supermarts Ltd. | 2.71% |
Name | Assets |
---|---|
Reliance Industries Ltd. | 9.90% |
Grasim Industries Ltd. | 9.87% |
Larsen & Toubro Ltd. | 8.14% |
Life Insurance Corporation of India | 7.22% |
Coal India Ltd. | 6.15% |
NTPC Ltd. | 6.12% |
JIO Financial Services Ltd. | 5.69% |
Bajaj Finserv Ltd. | 4.83% |
Adani Enterprises Ltd. | 4.73% |
Aurobindo Pharma Ltd. | 4.18% |
Name | Anil Ghelani | Ankit A Pande |
Start Date | 24 Jul 2019 | 22 Aug 2023 |
Name
Start Date
Description | The scheme seeks to invest in companies which are constituents of NIFTY Next 50 Index (underlying Index) in the same proportion as in the index and seeks to generate returns that are commensurate (before fees and expenses) with the performance of the underlying Index. | The scheme seeks to provide capital appreciation by investing in a focused portfolio of Large cap -'bluechip' companies |
Launch Date | 11 Feb 2019 | 03 Jul 2008 |
Description
Launch Date